FDA Approves Label Update For Biofrontera’s Ameluz Gel To Highlight Hypersensitivity Warnings

Benzinga Newsdesk www.benzinga.com Neutral 93.6%

Neg 0% Neu 93.6% Pos 0%

https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/208081s040lbl.pdf

Comments

No comments yet. Be the first!